GLP-1 drugs , or glucagon-like peptide-1 receptor agonists , represent a truly shift in how we handle type 2 diabetes . These injectable therapies help stimulating the body’s inherent GLP-1 hormone , which https://socialstrategie.com/story7513326/glp-1-a-significant-advance-in-diabetes-management